Mixed-methods approach to exploring patients’ perspectives on the acceptability of a urinary biomarker test in replacing cystoscopy for bladder cancer surveillance-Reference-Cited by-同舟云学术

Mixed-methods approach to exploring patients’ perspectives on the acceptability of a urinary biomarker test in replacing cystoscopy for bladder cancer surveillance

Published:2019-03-04 Issue:3 Volume:124 Page:408-417
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Tan Wei Shen¹²^ORCID,Teo Chin Hai³,Chan Delcos³,Heinrich Malgorzata⁴,Feber Andrew¹⁵,Sarpong Rachael⁶,Allan Jennifer¹,Williams Norman⁶,Brew-Graves Chris⁶,Ng Chirk Jenn³,Kelly John D.¹²,

Affiliation:

1. Division of Surgery and Interventional Science; University College London; London UK

2. Department of Urology; University College London Hospital; London UK

3. Department of Primary Care Medicine; Faculty of Medicine; University of Malaya; Kuala Lumpur Malaysia

4. Health Behaviour Research Centre; Department of Epidemiology and Public Health; University College London; London UK

5. UCL Cancer Institute; London UK

6. Surgical and Interventional Trials Unit; University College London; London UK

Funder

Urology Foundation

Mason Medical Research Trust

Medical Research Council

UCLH Biomedical Research Centre

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.14690/fullpdf

Reference17 articles.

1. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016;Babjuk;Eur Urol,2017

2. Who should be investigated for haematuria? Results of a contemporary prospective observational study of 3556 patients;Tan;Eur Urol,2018

3. EORTC nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non-muscle-invasive stage Ta-T1 urothelial bladder cancer patients treated with 1-3 years of maintenance Bacillus Calmette-Guerin;Cambier;Eur Urol,2016

4. Management of non-muscle invasive bladder cancer: a comprehensive analysis of guidelines from the United States, Europe and Asia;Tan;Cancer Treat Rev,2016

5. The economics of bladder cancer: costs and considerations of caring for this disease;Svatek;Eur Urol,2014

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hematuria Cancer Risk Score with Ultrasound Informs Cystoscopy Use in Patients with Hematuria;European Urology Oncology;2024-05

2. Xpert Bladder Cancer Monitor for the Early Detection of Non-Muscle Invasive Bladder Cancer Recurrences: Could Cystoscopy Be Substituted?;Cancers;2023-07-19

3. Perception of urinary biomarker tests among patients referred with suspected urological malignancy;BJUI Compass;2023-04-03

4. The Role of Novel Bladder Cancer Diagnostic and Surveillance Biomarkers—What Should a Urologist Really Know?;International Journal of Environmental Research and Public Health;2022-08-05

5. Computed tomography urography with corticomedullary phase can exclude urinary bladder cancer with high accuracy;BMC Urology;2022-04-12